DiviDrip · TRAW

TRAW — Traws Pharma, Inc.

TRAW is Traws Pharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.54. Market cap: $9M. Capital Quality Rank: 61/100 — Above average.

Stock snapshot

Price$0.54
Market cap$9M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)61 / 100 · Above average
Revenue CAGR (3y)131.1%
Shareholder buyback yield0.00%
Altman Z-score zoneDistress

About TRAW

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.

Listed2013Employees7HQNewtown, PASectorHealthcareWebsitetrawspharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TRAW. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TRAW's current stock price?

TRAW (Traws Pharma, Inc.) is currently trading at $0.54.

Does TRAW pay a dividend?

TRAW (Traws Pharma, Inc.) does not currently pay a regular dividend.

What is TRAW's Capital Quality Rank?

TRAW has a Capital Quality Rank of 61/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TRAW in DiviDrip

Add TRAW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow